K940242 is an FDA 510(k) clearance for the VENTANA CEA PRIMARY ANTIBODY. This device is classified as a Kappa, Peroxidase, Antigen, Antiserum, Control (Class II - Special Controls, product code DFD).
Submitted by Ventana Medical Systems, Inc. (Tucson, US). The FDA issued a Cleared decision on December 23, 1996, 1069 days after receiving the submission on January 19, 1994.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5550.
| 510(k) Number | K940242 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | January 19, 1994 |
| Decision Date | December 23, 1996 |
| Days to Decision | 1069 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DFD — Kappa, Peroxidase, Antigen, Antiserum, Control |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.5550 |